SELICK HAROLD E received a stock award from PROTAGONIST THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2025ACC: 0001104659-25-001430
Director
Since Apr 2019
+11.71K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
11.71K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.13K
Price / share
—
Trade value
—
% of position
18.3%
1/2/2025
28K→33.13K
Total
Net shares
+5.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | A · Award | +5.13K | — | — | 18.3% | 28K | 33.13K |
| Total | +5.13K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
6.58K shares
Shares
+6.58K
Strike price
38.98
Held after
6.58K
Exercisable
—
1/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock6.58K shares | 1/2/2025 | A · Award | +6.58K | 38.98 | — | 6.58K |